Page last updated: 2024-11-04

tetracaine and Alzheimer Disease

tetracaine has been researched along with Alzheimer Disease in 1 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guidi, I1
Galimberti, D1
Lonati, S1
Novembrino, C1
Bamonti, F1
Tiriticco, M1
Fenoglio, C1
Venturelli, E1
Baron, P1
Bresolin, N1
Scarpini, E1

Other Studies

1 other study available for tetracaine and Alzheimer Disease

ArticleYear
Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
    Neurobiology of aging, 2006, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Case-Control Studi

2006